Market Research Reports

  The single cell RNA sequencing technology is developed to detect genome, transcriptome and other multi-omics of single cells. It has an advantage of analyzing single cells comprehensively that has created unprecedented opportunities for resolving the cell heterogeneity by expanding gene expression. Further, the commercial availability of next generation sequencing and increased focus on single cell analysis along with the maturing bioinformatics approaches has allowed researchers to incorporate the technology in making discoveries. The dramatic improvement within the technology has allowed it for a better usage in embryonic development, cancer biology, and immunology research. The   single cell RNA sequencing market   is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021–2031. Global Single Cell RNA Sequencing Market Segmentation North America represented one o

  The market for brain imaging modalities devices is rapidly growing, with an increasing number of modalities used in the imaging of various brain diseases and neurogenerative disorders (NDs). The high prevalence and growing incidences of neurological disorders (NDs) are one of the major factors augmenting the growth of the global brain imaging modalities market. Neurological diseases and mental disorders have emerged as serious public health concerns and substantial challenges to healthcare systems around the world. Genetic disorders, congenital anomalies or disorders, infections, lifestyle, or environmental health problems such as malnutrition, brain injury, spinal cord injury, or nerve injury are some of the causes of neurological problems. The global brain imaging modalities market is projected to witness significant growth during the forecast period 2022-2031. The high prevalence and growing incidences of brain diseases and neurogenerative disorders and the technological advanceme

  As per the National Cancer Institute, minimally invasive surgery is defined as, “surgery that is done using small incisions (cuts) and few stitches. During minimally invasive surgery, one or more small incisions may be made in the body. A laparoscope (thin, tube-like instrument with a light and a lens for viewing) is inserted through one opening to guide the surgery. Tiny surgical instruments are inserted through other openings to do the surgery. Minimally invasive surgery may cause less pain, scarring, and damage to healthy tissue, and the patient may have a faster recovery than with traditional surgery.” The global   minimally invasive surgical systems market   is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031. Impact of COVID-19 The COVID-19 pandemic had a huge impact on elective surgical procedures in the first half of 2020. The COVID-19 pandemic has drastically impac

  Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare. The ability to tailor the diagnostics and therapeutics offered to the patients is the key to precision medicine. The combination of biotechnology development, digitization of healthcare, the public investment led to the evolution of the personalization of disease-based therapies. The precision medicine concept is a systematic process aiming to achieve victory over a disease such as cancer. Cancer is the major focus of various precision medicine initiatives, and precision oncology centers around matching the most accurate and precise treatment to each cancer patient on the basis of an individual’s matching genetic profile that could ultimately let them benefit from the treatment offered. The global   oncology precision medicine market   was valued at $45,174.2 million in 2020 and is expected to reach $1,28,891.6 million by 2031, growing at a CAGR of 10.05% during the

  The global precision medicine market is projected to reach  $278.61 billion  by 2030, reveals a premium market intelligence report by BIS Research. The study also highlights that the market is set to witness a CAGR of 11.13% during the period between 2020 and 2030.  The comprehensive study of the global precision medicine market by BIS Research extensively covers the following: Market numbers on micro-segments that are influencing the market  More than 1500 products present in the market Pricing data for more than 500 products Over 350 brands were evaluated  Market share analysis for more than 20 product categories End-user preference data for over 50 end users Detailed global and regional market share analysis including the scrutiny of more than 15 countries  Study of data of more than 60 companies The detailed report is a compilation of 19 Market Data Tables and 330 Figures spread through 529 Pages and in-depth TOC on " Global Precision Medicine Market" Besides these para

According to a new market intelligence report by BIS Research, titled  " Global Precision Medicine  Market-  Analysis and Forecast, 2017-2026 " , the global precision medicine market accounted for  $43.59 billion  in 2016 and is estimated to reach  $141.70 billion  by 2026. The market is expected to grow at a compound annual growth rate (CAGR) of 11.23% between the years 2017 and 2026, aided by the adoption of early diagnosis, increased number of adverse drug reactions cases, high prevalence of chronic diseases, and advancements in genetic science, among others.    Browse  60  market Data Tables and  278  Figures spread through  580  Pages and in-depth TOC on " Global Precision Medicine  Market " Precision medicine is an emerging approach which enables the investigation of various diseases by evaluating the genetic makeup of an individual subject, thereby, providing a tailored therapeutic treatment to each patient. According to the Personalized Medicine Coalition, t

  Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy and is broadly used for nucleic acid analysis and protein analysis applications. Our healthcare experts have found the  Capillary electrophoresis market  to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031. Factors fueling the growth of the market include strategic initiatives by key market players and increasing adoption of sequencing in various research fields increase in adoption of personalized medicine; despite rap